SCHEMBL20334352

SCHEMBL20334352

O=C(O)c1cccc(Nc2ccc(O)c3c2C(=O)c2ccccc2C3=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 7/20 0.62
▸ PLAUR Q03405 3/20 0.58
▸ MEN1 O00255 3/20 0.57
▸ MAPT P10636 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ MAP2K7 O14733 2/20 0.57
▸ MAPK1 P28482 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ NPSR1 Q6W5P4 2/20 0.57
▸ NSD2 O96028 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ CDC25A P30304 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ MCL1 Q07820 1/20 0.57
▸ ATM Q13315 1/20 0.57
▸ PRKCA P17252 2/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ NPC1 O15118 1/20 0.54
▸ LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10794537 0.85 CDC25B (0.61) CDC25BPLAURMEN1MAPTKMT2A
SCHEMBL10791991 0.85 MAPT (0.64) CDC25BMEN1MAPTKMT2AMAPK1
SCHEMBL29500408 0.85 MEN1 (0.70) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL341146 0.85 MEN1 (0.70) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL10808217 0.82 GNG2 (0.62) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL11121841 0.82 PRKCA (0.58) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL13921521 0.82 PRKCA (0.58) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL11605704 0.80 MAPT (0.60) MEN1MAPTKMT2AMAPK1RAB9A
SCHEMBL10789018 0.79 P2RY4 (0.60) CDC25BPLAURMEN1MAPTKMT2A
SCHEMBL13884857 0.79 PRKCA (0.55) PLAURMEN1MAPTKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed
EP-3558235-B1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION OREAL (FR) 2021-09-08 — — EP disclosed
WO-2018115337-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2018-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION KRT18, CUTA, KLK5 CDC25B 3003/4885PLAUR 4194/4885MEN1 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback